- Edwards Pauses Enrollments In Pivotal Mitral, Tricuspid Trials In Response To Hospitals' Focus On COVID-19
- Edwards Lifesciences To Present At The Cowen 40th Annual Healthcare Conference
- Edwards Lifesciences' Every Heartbeat Matters Philanthropic Initiative Expanding To Reach More Patients
- Edwards Lifesciences Reports Fourth Quarter Results
- Edwards Lifesciences To Host Earnings Conference Call On January 30, 2020
- Edwards Lifesciences To Present At The 38th Annual J.P. Morgan Healthcare Conference
Edwards Lifesciences Corp (EW:NYQ) closed at 198.15, 28.24% above the 52 week low of 154.52 set on Mar 23, 2020.
154.52Mar 23 2020247.64Nov 19 2019
Markit short selling activity
|Market cap||41.08bn USD|
|EPS (TTM)||4.95 |
Data delayed at least 15 minutes, as of Mar 27 2020 22:30 BST.